873839-55-5Relevant articles and documents
NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
-
Page/Page column 67, (2010/11/28)
This present invention relates to novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1) antagonist; and a pharmaceutical composition containing the same. The present invention provides a pharmaceutical composition for preventing or treating a disease such as pain, inflammatory disease of the joints, neuropathies, HIV-related neuropathy, nerve injury, neurodegeneration, stroke, urinary bladder hypersensitivity including urinary incontinence, cystitis, stomach duodenal ulcer, irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), fecal urgency, gastro-esophageal reflux disease (GERD), Crohn's disease, asthma, chronic obstructive pulmonary disease, cough, neurotic/allergic/inflammatory skin disease, psoriasis, pruritus, prurigo, irritation of skin, eye or mucous membrane, hyperacusis, tinnitus, vestibular hypersensitivity, episodic vertigo, cardiac diseases such as myocardial ischemia, hair growth-related disorders such as effluvium, alopecia, rhinitis, and pancreatitis.
A method to greatly improve the enantioselectivity of lipase-catalyzed hydrolysis using sodium dodecyl sulfate (SDS) as an additive
Mori, Shuichi,Yumoto, Hiromi,Matsumi, Rina,Nishigaki, Tomohiro,Ebara, Yasuhito,Ueji, Shin-Ichi
, p. 3698 - 3702 (2007/10/03)
The addition of sodium dodecyl sulfate (SDS) resulted in a dramatic improvement of the enantioselectivity of the lipase-catalyzed hydrolysis of racemic butyl 2-(4-substituted phenoxy)propanoates, racemic butyl 2-(4-isobutylphenyl)propanoate, and racemic butyl 2-(6-methoxy-2-naphthyl) propanoate in an aqueous buffer solution. An increase in the E value by up to two orders of magnitude was observed for some esters. As to the effects of SDS on the structure of a lipase, FT-IR and fluorescence measurements suggest some conformational change and/or an increase of the flexibility of the lipase, although the native secondary structure of the lipase is held even in the presence of 100 mM SDS. The origin of the enantioselectivity enhancement brought about by the addition of SDS is briefly discussed on the basis of the values of the initial rates obtained for each enantiomer of the substrate.
Flexibility of lipase brought about by solvent effects controls its enantioselectivity in organic media
Ueji, Shin-ichi,Taniguchi, Tomohiko,Okamoto, Takashi,Watanabe, Keiichi,Ebara, Yasuhito,Ohta, Hitoshi
, p. 399 - 403 (2007/10/03)
The behavior of the enantioselectivity of Candida rugosa lipase was studied in the esterification of 2-(4-substituted phenoxy)propionic acids with 1-butanol in aliphatic, aromatic, and ethereal solvents, (cyclohexane, heptane, toluene, benzene, isooctane, dibutylether, etc.). Changing the solvent from cyclohexane to tert-butyl methyl ether, the isotropic signal increased quickly and the spectral line narrowed in width. The enzyme enantioselectivity in organic solvents was mainly controlled by its flexibility. The enantioselectivity of lipase in organic solvents was closely correlated with the lipase flexibility brought about by the cooperative solvent effects rather than with a sole solvent property, e.g., dielectric constant and hydrophobicity.
